Natixis Advisors, L.P. Meridian Bioscience Inc Transaction History

Natixis Advisors, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$31.15 - $33.39 $41,927 - $44,942	1,346 Added 12.61%	12,018 $399,000
Q3 2022 Nov 14, 2022	BUY	$30.9 - $33.55 $329,764 - $358,045	10,672 New	10,672 $336,000
Q2 2019 Aug 12, 2019	SELL	$10.88 - $17.6 $1.19 Million - $1.93 Million	-109,666 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$15.51 - $17.61 $774,336 - $879,179	49,925 Added 83.57%	109,666 $1.93 Million
Q4 2018 Feb 13, 2019	BUY	$14.52 - $19.72 $867,439 - $1.18 Million	59,741 New	59,741 $1.04 Million

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.